![]() Pharvaris Pharvaris is a clinical-stage company focused on the discovery and development of oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. | ||||
Founding Date | Founding Date 1971 | Founding Date 2005 | Founding Date 1974 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private | Type Public |
Tags | ||||
Locations | Locations Ledbury, GB HQ | Locations Letchworth Garden City, GB HQ Stevenage, GB | Locations RO HQ | Locations Zug, CH HQ Leiden, NL Lexington, US |
Employees | Employees 1041% increase | Employees 972% increase | Employees 618% decrease | Employees 108 |

DLRC is a company that provides regulatory affairs solutions for global healthcare.
View company
Pharvaris is a clinical-stage company focused on the discovery and development of oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.
View company